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with 10 MV and 150 kVp X-rays. In addition, analysis of the 150 kVp survival curve data indicates a
change in radiation quality, becoming more lethal for irradiated cells exposed to CeO2 nanoparticles. We
attribute the change in efficacy to an increase in high linear energy transfer Auger electron production at
150 kVp which counterbalances the CeO2 nanoparticle radioprotection capability and locally changes the
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Abstract
This article pioneers a study into the influence of the high-Z component of nanoparticles
on the efficacy of radioprotection some nanoparticles offer to exposed cells irradiated with Xrays. We reveal a significant decrease in the radioprotection efficacy for cells exposed to CeO2
nanoparticles and irradiated with 10 MV and 150 kVp X-rays. In addition, analysis of the
150 kVp survival curve data indicates a change in radiation quality, becoming more lethal for
irradiated cells exposed to CeO2 nanoparticles. We attribute the change in efficacy to an increase
in high linear energy transfer Auger electron production at 150 kVp which counterbalances the
CeO2 nanoparticle radioprotection capability and locally changes the radiation quality. This
study highlights an interesting phenomenon that must be considered if radiation protection
drugs for use in radiotherapy are developed based on CeO2 nanoparticles.
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1

The application of nanotechnology to medicine provides an innovative approach that can

2

enhance the effectiveness of radiotherapy 1 . Targeted and non-targeted tissues and cells are,

3

in general, damaged along an indirect pathway during radiation treatment as a result of the

4

production of free radicals 2 . Free radical production can result in chemical reactions that damage

5

DNA molecules and initiates apopotosis and mitotic death 3,4 . The protective mechanisms of a

6

cell in response to ionizing radiation exposure are insufficient and have prompted the research and

7

development of novel nanoparticles (NPs) with the ability to enhance or assist cell protective

8

mechanisms. If such NPs act preferentially and protect normal tissues that surround target

9

tissues it would allow dose escalation to the target for better tumour control and hence improved

10

patient outcomes.

11

One novel nanoparticle currently under investigation for its ability to provide protection against
2

12

radiation induced damage is cerium oxide (CeO2 ) 5 . Previous studies investigated the free-radical

13

scavenging effectiveness of CeO2 NPs to provide radioprotection in vitro for a variety of normal

14

cell lines, and in vivo with athymic nude mice 6,7 . CeO2 NPs inherit an autoregenerative cycle

15

(Ce3+ – Ce4+ – Ce3+ ) that enables continued antioxidant activity, providing long-term scavenging

16

of reactive oxygen species (ROS) 8 . CeO2 NPs now offer a prospective alternative to the only

17

clinically used radioprotector — amifostine 9 . Amifostine has the limitation of considerable side

18

effects, a short half-life in serum and high cost caused by frequent dosing requirements 3 .

19

Many avenues need to be explored prior to the clinical acceptance of CeO2 NPs and its application

20

as a radioprotector. Current investigations using CeO2 NPs explore characteristics such as:

21

its bioavailability/toxicity 10–12 , the ability to provide radiation protection by scavenging free

22

radicals and the selective nature of its protection to normal and cancerous cells 7 . However, steps

23

towards the clinical acceptance of CeO2 NPs requires an understanding of its effectiveness across

24

a range of beam energies. To the best of our knowledge, the influence of the above effects have

25

never been reported in the literature.

26

X-rays used throughout clinical treatments produce free radicals through interactions with mat-

27

ter 2 . Interactions of interest include — photoelectric and Compton effects, coherent scattering

28

along with pair production at higher energies. The most influential factors dictating the cross-

29

section for these interactions is the radiation energy (E) and atomic number (Z). The mass

30

attenuation coefficient due to the photoelectric effect is approximately proportional to (Z/E)3 ,

31

where Z is the atomic number of the absorbing medium and E is the photon energy 13 . The use of

32

high-Z nanoparticles (i.e. gold NPs, ZAu = 79) in dose enhancement provides an example of how

33

we can exploit the dependence of the photoelectric effect 13–15 . The majority of Auger electrons

34

are produced as a consequence of the photoelectric effect supporting the notion that their

35

greatest abundance is achieved when the cross-section for the photoelectric effect is maximised.

36

Compton interactions occur with outer shell electrons and subsequently, have no significant Z

37

dependence 16 . A threshold photon energy of 1.022 MeV exists for pair production, with a cross

38

section that increases rapidly with energy above the threshold 13 . Furthermore, pair production

39

cross-section has a quadratic proportionality with Z. The linear energy transfer (LET) is a

40

measure of the energy locally imparted to a medium by a secondary charged particle of energy

41

(E) along its path 2,16 . The variation of the LET with decreasing electron energy is an important
3

42

consideration in our study as increases in LET correspond to increases in the relative biological

43

effectiveness (RBE) of the radiation field 17 . Auger electrons have a LET that lies in the range of

44

10 - 25 keV/µm 18 while the positron-electron pair produced during the pair production process

45

with kinetic energy of a few MeV have a LET of 0.2 keV/µm 17 . Ultimately, Auger electrons

46

deposit their energy along their tracks in a very short range, indicating an increase in the

47

biological effectiveness of radiation exposure at lower energies 13 . CeO2 is a known radioprotector

48

however, the high-Z (ZCe = 58) component of this material is the major contributor towards

49

potential increases in the RBE.

50

In this article, we postulate that CeO2 NPs efficacy to function as a radioprotector is dependent

51

on the energy of X-rays used during treatment and we investigated this energy-dependence using

52

150 kVp X-ray and 10 MV photon beams. Furthermore, to prove the existence of any high-Z

53

enhancement abilities that CeO2 may possess, we select the radioresistant 9L cell line.

54

Cell survival curves are an effective analytical method that we utilise to measure the effectiveness

55

of CeO2 NPs to provide radioprotection. Radiobiological properties such as radiosensitivity and

56

repair accumulation can be extracted using this analysis, where the influence on these parameters

57

by the CeO2 NP are determined for the first time.

58

Our study reveals an energy-dependent efficacy due to the influence of the high-Z component

59

of CeO2 NPs (Zef f = 54). At 10 MV, indirect damage effects dominate and mainly results

60

from the interaction of molecules contained in cells and the free radicals produced during the

61

radiolysis of water. The radioprotection provided by CeO2 NPs is achieved using free-radical

62

scavenging effects, facilitating increased repair while lowering the cells radiosensitivity. At lower

63

X-ray beam energies, the probability of direct damage effects become an increasingly important

64

consideration and are no longer negligible 17 . Low energy secondary electrons have an increased

65

probability to produce clusters of free radicals that can provoke the rupture of covalent bonds

66

and scissions in the molecules contained within cells 17 . The additional presence of free radicals

67

cannot be fully managed by the scavenging abilities of CeO2 , adding further weight to increased

68

damaging effects at lower energies. The work described in this article reveals that the free-radical

69

scavenging effect is counterbalanced by the high-Z atoms present in the elemental composition

70

of CeO2 . These high-Z atoms are responsible for an increased production of lethally damaging,

71

low energy secondary electrons.
4

72

Methods

73

Cell line

74

The rat brain gliosarcoma cell line (9L) was obtained from the European Collection of Cell

75

Cultures (ECACC). Derived from a N-nitrosomethylurea-induced tumour, this adherent radiore-

76

sistant cell line inherits glial morphology and has undergone routine mycoplasma contamination

77

testing.

78

Cell culture

79

The 9L gliosarcoma cells were grown and maintained during their exponential growth phase

80

in T75 cm2 BD FalconTM tissue culture flasks (Franklin Lakes, NJ, USA) containing Dulbecco’s

81

Modified Eagle Medium (DMEM) with L-Glutamine, supplemented with 10% (v/v) Fetal Bovine

82

Serum (FBS) and 1% (v/v) Penicillin/Streptomycin (PenStrep). Cell cultures were passaged

83

upon reaching 85% confluence to a concentration of 2–4 × 104 cells/cm2 and stored at 37◦ C in

84

a 5% (v/v) CO2 cell culture incubator. In our hands, the cell doubling time was deduced to

85

be 36 h. All chemical reagents used were purchased from GIBCO R , unless indicated otherwise.

86

All cell culture work was carried out at the Illawarra Health and Medical Research Institute

87

(Wollongong, NSW, Australia).

88

Nanoparticle synthesis and preparation

89

The cerium oxide nanoparticle sample was synthesised at the Institute for Superconducting

90

and Electronic Materials (Wollongong, NSW, Australia) using a spray pyrolysis technique 19,20 .

91

This synthesis approach produces compounds of high purity and chemical homogeneity, yielding

92

a nanoparticle with reproducible size and characteristics. A 1 L aqueous solution was prepared,

93

consisting of 0.45 mol/L of Ce(NO3 )3 and 6H2 O. This solution was sprayed and decomposed at

94

500◦ C using a customised spray pyrolysis system designed for the engineering of nanoceramics

95

and composites. Cerium oxide NP samples were dried prior to sterilisation using an open furnace

96

operating at 140◦ C for a period no less than 2 h. Sterilisation was achieved using an autoclave

97

operating at 121◦ C on a dry cycle, with sterilised samples kept in glass vials surrounded by silica

98

gel to avoid moisture absorption. Cerium oxide NPs were dispersed in Dulbecco’s Phosphate-

99

Buffered Saline (DPBS) to solubilise the NP. Sonication and vortex mixing was used to minimise
5

100

the size of NP aggregates and increase the homogeneity of dispersion prior to exposure. A

101

concentration of 50 µg/ml was applied to 9L cells for subsequent analysis.

102

X-ray Diffraction

103

A slurry of nanoparticle was produced via vigorous mixing with 100 % ethanol which was

104

placed onto a quartz sample holder. The sample was presented to the monochromatic, copper Kα

105

X-ray beam (λ = 1.5406 Å). The X-ray diffraction analysis was performed using an automated

106

GBC R eMMA X-ray Diffractometer (GBC, VIC, Australia) where the sample was scanned using

107

a step size of 0.2◦ 2θ through the range of 20◦ - 70◦ 2θ with a count time of 8.75 seconds per

108

step. The operational settings used were 25 mA and 40 kVp. Phase identification was extracted

109

by comparing the recorded diffraction pattern with the Inorganic Crystal Structure Database

110

(ICSD). The average nanoparticle crystallite size (T c) is extracted from the X-ray diffraction

111

data using Scherrer’s equation (1).

Tc =
112

Kλ
βcos(θB )

(1)

K is the shape factor constant (K = 0.89), λ is the X-ray beam wavelength, β is the FWHM

113

(in radians) and θB is the Bragg angle.

114

Transmission Electron Microscopy

115

Transmission electron microscopy (TEM) was performed using a JEOL 2011 high resolution

116

(HR) instrument, characterising the size and morphology of the sample. The samples were

117

prepared by dispersion of CeO2 powders onto holey carbon support films.

118

Gas sorption analysis

119

The specific surface area of the powder samples was measured by the Brunauer-Emmett-

120

Teller (BET) method with a Nova 1000 high speed gas sorption analyser from Quantachrome,

121

using the adsorption of N2 at the temperature of liquid nitrogen. Prior to measuring, the samples

122

were degassed at 120◦ C for 2 h 30 min in vacuum.

6

123

Irradiation of cell culture

124

All irradiations were performed in the radiation oncology department at the Prince of Wales

125

Hospital (Randwick, NSW, Australia). The confluent cell culture was irradiated following a

126

24 h incubation period with cerium oxide nanoparticles at a concentration of 50 µg/ml. Prior

127

to megavoltage irradiation, non-vented T12.5 cm2 tissue culture flasks (BD FalconTM ) were

128

completely filled with Hank’s Balanced Salt Solution (HBSS) to ensure no air bubbles were

129

present inside the flask, maximising the accuracy of the dose delivered at the depth of the cells.

130

Kilovoltage irradiation was performed using only a 6 mm depth of medium in an attempt to

131

maximise the accuracy of the dose delivered to the cell monolayer. Beam energies of 10 MV

132

and 150 kVp were explored using an Elekta AxesseTM LINAC (Elekta AB, Kungstensgatan,

133

Stockholm, Sweden) and a Nucletron Oldelft Therapax DXT 300 Series 3 Orthovoltage unit

134

(Nucletron B.V., Veenendaal, The Netherlands), respectively. All doses (1, 2, 3, 5 & 8 Gy)

135

were delivered in single fractions at room temperature. Tissue culture flasks were irradiated in

136

a horizontal orientation with solid water placed both underneath and around the sides of the

137

flasks, primarily to maintain adequate backscattering effects and stabilise electronic equilibrium.

138

Unirradiated control samples (with and without CeO2 NPs) were utilised and handled under the

139

same conditions as the irradiated samples.

140

Clonogenic cell survival assay

141

Cell survival was assessed using a clonogenic cell survival assay, otherwise known as a colony-

142

forming assay 21,22 . Adherent cell lines, such as 9L, have the ability to form colonies in vitro even

143

at low density cell seeding. Following radiation exposure, all of the flasks were promptly plated,

144

initiating the clonogenic assay (duration of 15 doubling times for 9L cells). The growth media was

145

removed and the confluent cell culture was thoroughly washed with DPBS containing no calcium

146

(Ca) or magnesium (Mg) salts. The cells were then detached from the surface of the flask with a 2-

147

3 minute incubation with 0.05% trypsin ethylenediaminetetraactic acid (Trypsin-EDTA), forming

148

a cell suspension that was counted using a haemocytometer. Cells were seeded at low densities in

149

triplicate into 100 mm Sigma-Aldrich R petri dishes containing 10 ml of the DMEM. All plates

150

were incubated at 37◦ C and 5% CO2 for 15 cell doubling times. Each prescribed dose used a

151

maximum of three different cell seeding numbers, all determined by preliminary experiments to
7

152

narrow the optimal seeding to achieve an approximate number of colonies of 100. Following the

153

incubation period, formed colonies were fixed and stained using a solution comprised of 75%

154

(v/v) ethanol and 25% (v/v) crystal violet (Sigma-Aldrich R ). Colonies containing 50 cells or

155

more, confirmed by the use of a high powered inverted microscope are counted for analysis.

156

Cell survival data is presented using the relative surviving fraction of cells as a function of

157

absorbed dose. The surviving fraction is extracted from the plating efficiency. The Plating

158

Efficiency (PE) is calculated as the ratio of viable colonies to cells seeded.

PE =
159

160

N o. of colonies counted
N o. of cells seeded

The Surviving Fraction (SF) was determined by comparing the PE at a given dose to the
control (i.e. no dose). The surviving fraction is given by:

SF (D) =
161

162

(2)

P E(D)
P E(0)

(3)

where SF(D) and PE(D) is the surviving fraction and plating efficiency at dose D (Gy),
respectively.

163

PE(0) is the plating efficiency of unirradiated controls (0 Gy) with or without NPs used for

164

normalisation of irradiated samples with or without NPs, respectively. The plating efficiencies

165

given are the mean PE values from duplicate samples at each dose.

166

167

Statistical analysis

168

Cell survival experiments were replicated once and measured in triplicate on each occasion.

169

The reported values are the mean of all experiments, with the experimental uncertainty given

170

as one standard deviation. The LQ model was fitted to cell survival data using KaleidaGraph

171

software. The fit of the data is weighted by the reported error at each dose in the determination of

172

the radiobiological constants of the LQ model. Statistical analysis of toxicity data was performed

173

using a two-tailed Student’s t -test using the assumption of equal variance. A P value of ≤ 0.05

174

was considered statistically significant.

8

175

Cell survival analysis

176

The cell survival curves are constructed on a semi-logarithmic plot of the surviving fraction

177

as a function of absorbed dose. The cell survival curve can be represented mathematically using

178

the linear quadratic (LQ) model as X-ray (i.e. low LET) radiation sources are used 2,23 .

SF (D) = exp(−αD − βD2 )
179

(4)

The parameters α (Gy−1 ) and β (Gy−2 ) are measures of the radiosensitivity and repair

180

accumulation, respectively.

The surviving fraction data was fitted to the LQ model using

181

KaleidaGraph software, extracting the α and β constants for each set of cell survival data.

182

Protection enhancement ratio

183

The Protection Enhancement Ratio (PER) is a value used to measure the degree of protection

184

achieved using CeO2 NPs. The PER can be defined as the ratio of doses in the presence of CeO2

185

to the control (i.e. no NP), as measured at the common endpoint of 10 % cell survival.

P ERSF =10% =

DoseCeO2
Dosecontrol

(5)

186

A PER value greater than 1 is indicative of radioprotection, whereas a PER value less than 1

187

reveals a sensitisation effect. This effect is manifested as a direct result of the presence of CeO2

188

NPs.

189

Results

190

Phase and structural characterisation of cerium oxide

191

The biochemical effect of nanoparticles are dependent on their structural and physical char-

192

acteristics. Characteristics of particular interest include: phase composition, structure and

193

crystallite size. First order diffraction peaks have been labelled (Figure 1, A) upon correlating

194

recorded data against the ICSD (PDF card no. 01-089-8436). Cerium oxide nanoparticle’s phase

195

is confirmed to exist as CeO2 . This matches the phase of the cerium oxide NPs that have been

196

reported to provide protection in response to exposure of ionising radiation 3,5–7 . Using the XRD

9

197

data, the structure of the sample can be extracted. The CeO2 NP sample has a simple cubic

198

crystalline structure with a single lattice parameter, a = 5.4112 Å. The average crystallite size

199

can be extracted from the XRD peaks using Scherrer’s equation. The most accurate analysis

200

is achieved by selecting the most pronounced peaks, free of any contribution from surrounding

201

satellite peaks. The average crystallite size was calculated to lie in the range of 6–8 nm, consistent

202

with the crystallite sizes observed in the HR-TEM image (Figure 1, B). The high resolution

203

transmission electron micrograph (HR-TEM) shows clear lattice fringes (Figure 1, B) with a

204

fringe spacing (d) of 3.15 Å, which corresponds to the distance between the 111 lattice planes of

205

CeO2 . The calculated BET specific surface area of the nanocrystalline powder was 51 m2 /g.

206

Toxicity of CeO2 NPs to 9L cells

207

No definitive conclusions have been made regarding the toxicity of CeO2 NPs 3,6,7,24 . Efforts

208

to determine its biological viability remains the subject of numerous studies and is an integral

209

component to the development of any model using CeO2

210

toxicity of our synthesised CeO2 NP to 9L cells. The clonogenic cell survival assay was conducted

211

following a 24 h incubation with CeO2 NPs at a range of concentrations up to 500 µg/ml. We

212

established that the application of CeO2 NPs had no statistically significant toxic effect on the

213

surviving fraction of 9L cells at 50 µg/ml (Figure 2) where we found a surviving fraction of

214

0.93 ± 0.07 (P value: 0.2, CeO2 vs no NP control). The toxicity of CeO2 NPs is found to

215

be concentration dependent and this effect should be considered when implementing CeO2 as a

216

radioprotector.

217

Efficacy of CeO2 NPs when used in synergy with different X-ray beams

8,10,11,24–27

. Initially, we investigated the

218

The gliosarcoma cell line, 9L, was exposed to CeO2 NPs at a concentration of 50 µg/ml during

219

a 24 h incubation period prior to irradiation. The control flasks were incubated in the absence

220

of the NP. All conditions remained constant besides the presence and absence of the NP. The

221

first X-ray beam used was a 150 kVp beam and was chosen for both, its clinical relevance and to

222

maximise the dose enhancement to the CeO2 doped medium to a water equivalent medium based

223

on the formalism described by Corde et al. 28 The 150 kVp beam produces an effective energy

224

of 65 keV which lies close to, yet above the energy required to maximise dose enhancement (i.e.

10

225

54 keV). The cells were exposed to a range of doses up to 8 Gy. The samples were irradiated

226

using either a 150 kVp or 10 MV X-ray beam to probe the effectiveness of CeO2 NPs across a

227

range of beam energies. Cell survival curves were produced using the clonogenic cell survival

228

assay. This technique enabled any effect caused by the presence of the NP to be observed and

229

quantified. The results show that the 9L cell line has a response that varies with treatment

230

beam energy (Figure 3). The radiobiological parameters (α, β) for 9L cells are investigated for

231

different radiation sources in the presence and absence of CeO2 NPs. It is evident that CeO2

232

NPs exhibit a protective effect to 9L cells when irradiated using a 10 MV photon beam (Figure

233

3, A). A higher surviving fraction at all doses was observed in the presence of CeO2 NPs relative

234

to the control sample. The radiosensitivity of 9L cells decreases in the presence of CeO2 NPs

235

with a corresponding increase in the damage repair as portrayed throughout table 1. A PER

236

value of 1.23 ± 0.003 is achieved during the 10 MV treatment, confirming the radioprotective

237

ability of CeO2 NPs. A contrary effect is observed in response to exposure from the 150 kVp

238

X-ray beam (Figure 3, B), where the surviving fraction in the presence of CeO2 NPs is similar

239

to the 9L control sample, revealing the consequence of the high-Z component of CeO2 NPs. We

240

observe a minor increase in radiosensitivity of 9L cells in the presence of CeO2 coupled with

241

the lack of evidence of damage repair, which is confirmed from the linear trend of the survival

242

curve (Table 1). Subsequently, a PER close to unity is deduced, suggesting that CeO2 NPs

243

possess an energy-dependent radioprotection efficacy. We believe that a counterbalance between

244

the sensitisation effect caused by increases in the RBE at lower photon energies 15,29 and the

245

radioprotection offered through CeO2 ’s free-radical scavenging ability 6 is responsible for these

246

energy-dependent effects.

247

Discussion

248

The application of CeO2 NPs to clinical radiation protection is the subject of numerous

249

studies and development 3,5–7 . Nanomedicine is a vastly expanding and alternative approach to

250

existing medicines with applications ranging from diagnostic imaging and therapeutic radiation

251

enhancement to radiation protection 6,15,30 . Minimising radiation-induced side effects is the focus

252

of many studies and the catalyst in the production and development of novel approaches to

253

radiation protection 28,31 . Scavenging free radicals is the most common approach used to provide
11

254

radiation protection. Development of new and improved radioprotectors as an alternative to

255

amifostine is of great importance as a result of its clinical limitations 3,9 .

256

We synthesised CeO2 NPs using spray pyrolysis techniques for their application in radiation

257

protection. High nanoparticle yield and reproducible characteristics such as size, phase and

258

crystallinity are key advantages provided by our synthesising approach over alternative techniques

259

of nanoparticle production 32 . Characterisation of our synthesised sample using XRD revealed

260

important properties that were essential for our application. Results show that we have a

261

nanoparticle sample with a single cubic phase, existing as CeO2 upon comparison with the

262

ICSD. The broad diffraction peaks (Figure 1) confirm the nano-crystallinity of CeO2 , with

263

the mean crystallite size measured to range from 6–8 nm. Tarnuzzer et al. 7 report parallel

264

findings with their XRD analysis of CeO2 , enabling us to suggest that our synthesised sample

265

also exhibits these autoregenerative antioxidant effects for radiation protection. The HR-TEM

266

image of CeO2 shows crystallite sizes that correlate with that determined in our X-ray diffraction

267

analysis. Distinct lattice fringes are observed, supporting the presence of a cubic structure with

268

the distance between successive fringes deduced to be 3.15 Å, consistent with our diffraction data

269

and the PDF card no. 01-089-8436 as published in the ICS database. Light micrographs of 9L

270

cells incubated with CeO2 NPs show that they are randomly distributed, i.e. around, on and

271

alternately in the cells. However at such magnification, it is not possible to visualise intracellular

272

localisation. Using flow cytometric analysis we deduce that CeO2 NPs can be internalised in 9L

273

cells. The internalisation is confirmed as a result of increases in the measured cell side scatter

274

(data not shown), a technique utilised by Busch et al. 33 Results of the gas sorption analysis show

275

a nanocrystalline surface area of 51 m2 /g, supporting the nanoscale crystallite size recorded. It

276

is well known that the size of a nanoparticle is related its surface area, where smaller particles

277

have greater surface areas 11 . Increasing the surface area could therefore act to maximise any

278

related free-radical scavenging properties of CeO2 NPs.

279

The toxicity of CeO2 NPs to 9L cells was tested to elucidate its clonogenic survival at concen-

280

trations up to 500 µg/ml. We utilised mimetic experimental conditions to that used in radiation

281

exposures, maximising the validity of the reported outcomes. Following a 24 h incubation of

282

9L cells with CeO2 NPs, we report insignificant toxic effects at 50 µg/ml, consistent with other

283

published literature 6,7,27 . Inconsistent conclusions have been made in regard to the toxic effects
12

284

of CeO2 NPs, a factor requiring further development 26 . It is well documented that the size

285

and structure of nanoparticles, influenced by the production process, dictate their toxicity 6,26 .

286

Additional factors which should be investigated include: oxygen non-stoichiometry and balance

287

of Ce3+/Ce4+ cation states, exposure time, concentration and aggregation of the nanoparticle,

288

and also cell type as different toxic responses may occur 10 .

289

It has been well established that CeO2 NPs utilise a unique free-radical scavenging ability to

290

provide radioprotection in both cell culture and murine models. Important factors influencing

291

the effectiveness of CeO2 include: cell sensitivity, NP concentration and synthesis and these

292

factors should be further developed and understood in steps toward clinical acceptance.

293

Figure 3A clearly indicates that the CeO2 NPs provide protection against radiation induced

294

damage to gliosarcoma (9L) cells. Cell survival curves provide a wealth of information — not

295

only a comparison of the response of cells exposed to radiation in the presence and absence

296

of CeO2 , but the influence of CeO2 on the radiobiological parameters, α and β used in the LQ

297

model. Using a 10 MV photon beam, we record radioprotection at all doses up to 8 Gy with CeO2

298

NPs at a concentration of 50 µg/ml. This radioprotection is supported by the increase in damage

299

repair (β) and decrease in radiosensitivity (α) under the LQ model data interpretation observed

300

in the presence of CeO2 NPs. While statistically there is no significant difference between the

301

two survival curves at 150 kVp, analysis of the data under the LQ model indicates an increased

302

linearity of the survival curve in the presence of the NP. Investigation of the radiobiological

303

parameters within the LQ model shows a small increase in the radiosensitivity when CeO2 NPs

304

are present. Within the LQ model the increased linearisation is interpreted as a change in the

305

radiation spectrum. Therefore the increased linearity of the logarithmic cell survival suggests

306

that CeO2 NPs enable more direct damage effects to occur due to the additional enhancement

307

in the field of low energy electrons.

308

The observed energy dependence of the PER efficacy (for 10 MV and 150 kVp) can be explained

309

as a counterbalance between the free-radical scavenging ability of CeO2 and the increased RBE

310

due to lower energy radiations. The increase in the RBE is, in part, influenced by the macroscopic

311

dose enhancement from the mass-energy absorption of CeO2 and the increased yield of Auger

312

electrons 29,34,35 . This energy dependence is also influenced by the increased production of photo-

313

electrons, with a cross-section that is inversely proportional with energy (Figure 4). Photoelectric
13

314

interactions are important to consider for compounds such as CeO2 as the effective atomic

315

number (Zef f =54) 36 has a strong influence on the photoelectric cross-section 13 . Photoelectric

316

interactions stimulate two main processes – the ejection of characteristic X-rays and Auger

317

electron cascades 37,38 . Auger electrons increase the average LET of the resultant secondary

318

particles maximising the efficiency of these radiations through denser ionisations, imparting

319

more direct damage which in turn reduces the abundance of reactive oxygen species responsible

320

for indirect damage 17 . The 150 kVp X-rays yield a greater proportion of these higher LET

321

particles than the 10 MV photon beam in the presence of CeO2 NPs, supporting the energy

322

dependent efficacy of radioprotection that we observe. Ideally, a radioprotective compound

323

would have a low atomic number to minimise effects such as energy dependent protection. The

324

use of low-Z radioprotectors is supported by the current “gold standard” clinical radioprotector,

325

amifostine, which has a low effective atomic number (Zef f =11). As radioprotectors generally

326

function along a chemical pathway, the cross-section for the production of secondary particles

327

should be minimised. The effect of the atomic number on the total photon interaction cross-

328

section supports the notion that idealistic radioprotectors should have a low atomic number in

329

order to be less dependent of the X-ray field energy spectra (Figure 4, B).

330

In conclusion we have demonstrated that the radioprotection (via free-radical scavenging) efficacy

331

of the CeO2 nanoparticle depends on the spectra of X-ray radiation. Our hypothesis is that

332

the change in efficacy is driven by the high-Z component of CeO2 that leads to a modifica-

333

tion of the electron spectra in close proximity to the nanoparticles that can counterbalance

334

the radioprotection efficacy of CeO2 . The electron spectra is modified through the increased

335

production of low energy secondary electrons (including Auger cascades) that are generated

336

due to predominance of the photoelectric effect at kilovoltage X-ray energies. The influence

337

of these low energy electrons, with high LET, is reflected in the change of the shape of the

338

survival curve for 9L cells exposed to CeO2 nanoparticles and irradiated with 150 kVp X-rays

339

compared to 10 MV X-rays, which adds weight to our hypothesis. Therefore we have highlighted

340

a very interesting phenomenon that must be considered if radiation protection drugs for use in

341

radiotherapy are developed based on the CeO2 nanoparticle. This is particularly important in the

342

case of cancer treatment delivered by different photon fields (e.g. superficial cancer treatment

343

with 100 - 150 kVp photons in comparison with external beam radiotherapy delivered by 614

344

18 MV photons) where we have shown that the changes in the free-radical scavenging efficacy of

345

CeO2 nanoparticles are pronounced. The scientific interest in the development of CeO2 NPs as a

346

radioprotecting agent is evident throughout the widespread literature that contains both, in-vitro

347

and in-vivo models 3,5–8,10,24–27 . Expanding our knowledge in the application and functionality

348

of CeO2 NPs will continue with the long term goal of clinical implementation.
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Figure 1: X-ray diffraction spectrum of the CeO2 NP sample synthesised by spray pyrolysis (A). Data was
acquired using an automated GBC R eMMA X-ray Diffractometer. X-ray diffraction peaks were assigned Miller
indicies in correlation with the ICSD. High Resolution Transmission Electron Microscopy image of CeO2 NPs
synthesised using spray pyrolysis techniques (B).

Figure 2: The surviving fraction of 9L cells exposed to CeO2 NPs during a 24 h exposure at increasing
concentrations up to 500 µg/ml. The toxicity was measured using the clonogenic cell survival assay. Surviving
fraction data is presented with uncertainties given as one standard deviation with statistical significance measured
with a P value ≤ 0.05.

Figure 3: 9L clonogenic cell survival after irradiation with 10 MV (A) or 150 kVp (B) X-ray beams in the
presence (triangle) and absence (square) of CeO2 NPs at a concentration of 50 µg/ml. All uncertainties are
presented with one standard deviation made from duplicate samples which are measured in triplicate.

Figure 4: Energy dependence of the mass-energy absorption coefficients for the three main radiation interactions
are highlighted as a function of treatment beam energy for CeO2 (A). The total mass-energy absorption coefficients
for amifostine and CeO2 are shown over a range of energies (B) highlighting the influence on the mass-energy
absorption coefficient through increases in atomic number.

Table 1: Summary of the radiobiological parameters for 9L cells exposed to different radiation sources in the
presence and absence of CeO2 NPs. The LQ model was used to fit the surviving fraction data in KaleidaGraph,
extracting the α and β constants. All uncertainties listed are given as one standard deviation.
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Experimental Parameters
50 μg/ml

Control
Radiation source

α (Gy-1)

β (Gy-2)

α (Gy-1)

β (Gy-2)

150 kVp X-rays

0.21 ± 0.03

0.009 ± 0.004

0.30 ± 0.04

--

10 MV X-rays

0.20 ± 0.06

0.013 ± 0.008

0.06 ± 0.04

0.019 ± 0.005
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